Company Overview of Colby Pharmaceutical Company
Colby Pharmaceutical Company, a clinical stage drug development company, focuses on non-toxic signal transduction and hypoxia inhibitor drug therapeutics specifically targeting survival pathways in solid tumor cells, immune or immune suppressed cells, and vas-occlusive conditions. The company primarily focuses on therapeutic areas, such as prostate and brain cancer. Its products include CPC-100, an anti-androgenic, anti-inflammatory, multi-targeted signal transduction inhibitor drug for the treatment of androgen-dependent prostate tumors; CPC-200, a synthetic drug that irreversibly binds to and inactivates the oxidase enzyme producing hydrogen peroxide in the cell cytoplasm of various types ...
5941 Optical Court
San Jose, CA 95138
Founded in 2004
Key Executives for Colby Pharmaceutical Company
Chief Executive Officer and Director
Vice President and Director
Compensation as of Fiscal Year 2014.
Colby Pharmaceutical Company Key Developments
Colby Pharmaceutical Company Presents at 8th Annual OneMedForum 2015, Jan-12-2015
Dec 19 14
Colby Pharmaceutical Company Presents at 8th Annual OneMedForum 2015, Jan-12-2015 . Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States.
Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 01:00 PM
Nov 28 13
Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 01:00 PM. Venue: Four Seasons Hotel, San Francisco, California, United States. Speakers: David A. Zarling, Chief Executive Officer and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries